Bachert C, Vignola A M, Gevaert P, et al. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease[J]. Immunol Allergy Clin North Am, 2004, 24(1):19-43.
 Hofmann M A, Kiecker F, Zuberbier T. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases[J]. Curr Opin Allergy Clin Immunol,2016,16(5):451-457.
 Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines-from host defence to tissue homeostasis[J]. Nat Rev Immunol,2014,14(12):783-795.
 Pestka S, Krause C D, Sarkar D, et al. Interleukin-10 and related cytokines and receptors[J]. Annu Rev Immunol,2004,22:929-979.
 Fang P, Zhou L, Zhou Y, et al. Immune modulatory effects of IL-22 on allergen-induced pulmonary inflammation[J]. PLoS One,2014,9(9):e107454.
 Tamasauskiene L, Sitkauskiene B. Role of Th22 and IL-22 in pathogenesis of allergic airway diseases: Pro-inflammatory or anti-inflammatory effect?[J]. Pediatr Neonatol,2017, Article in Press.
 Dudakov J A, Hanash A M, van den Brink M R. Interleukin-22: immunobiology and pathology[J]. Annu Rev Immunol,2015,33:747-785.
 Manni M L, Alcorn J F. The enigmatic role of IL-22 in asthma[J]. Expert Rev Respir Med,2016,10(6):619-623.
 Takahashi K, Hirose K, Kawashima S, et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation[J]. J Allergy Clin Immunol,2011,128(5):1067-1076.
 Taube C, Tertilt C, Gyulveszi G, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease[J]. PLoS One,2011,6(7):e21799.
 Schnyder B, Lima C, Schnyder-Candrian S. Interleukin-22 is a negative regulator of the allergic response[J]. Cytokine,2010,50(2):220-227.
 Johnson J R, Nishioka M, Chakir J, et al. IL-22 contributes to TGF-beta1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells[J]. Respir Res,2013,14(1):118.
 Tang J, Xiao P, Luo X, et al. Increased IL-22 level in allergic rhinitis significantly correlates with clinical severity[J]. Am J Rhinol Allergy,2014,28(6):197-201.
 Wei P, Hu G H, Kang H Y, et al. Increased aryl hydrocarbon receptor expression in patients with allergic rhinitis[J]. QJM,2014,107(2):107-113.
 Sherkat R, Yazdani R, Ganjalikhani H M, et al. Innate lymphoid cells and cytokines of the novel subtypes of helper T cells in asthma[J]. Asia Pac Allergy,2014,4(4):212-221.
 Gallagher G. Interleukin-19: multiple roles in immune regulation and disease[J]. Cytokine Growth Factor Rev,2010,21(5):345-352.
 Huang F, Wachi S, Thai P, et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma[J]. J Allergy Clin Immunol,2008,121(6):1415-1421.
 Oral H B, Kotenko S V, Yilmaz M, et al. Regulation of T cells and cytokines by the interleukin-10(IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26[J]. Eur J Immunol,2006,36(2):380-388.
 Gallagher G, Eskdale J, Jordan W, et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses[J]. Int Immunopharmacol,2004,4(5):615-626.
 Higashino M, Takabayashi T, Takahashi N, et al. Interleukin-19 downregulates interleukin-4-induced eotaxin production in human nasal fibroblasts[J]. Allergol Int,2011,60(4):449-457.
 Fonseca-Camarillo G, Furuzawa-Carballeda J, Llorente L, et al. IL-10- and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis[J]. J Clin Immunol,2013,33(3):640-648.
 Commins S, Steinke J W, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28 and IL-29[J]. J Allergy Clin Immunol,2008,121(5):1108-1111.
 Gong W, Wang X, Zhang Y, et al. Interleukin-20 promotes airway remodeling in asthma[J]. Inflammation,2014,37(6):2099-2105.
 Wu J, Wang G, Hao J, et al. The correlation between IL-20 and the Th2 immune response in human asthma[J]. Asian Pac J Allergy Immunol,2014,32(4):316-320.
 Tan Y, Sanders A J, Zhang Y, et al. Interleukin-24(IL-24)Expression and Biological Impact on HECV Endothelial Cells[J]. Cancer Genomics Proteomics,2015,12(5):243-250.
 Panneerselvam J, Shanker M, Jin J, et al. Phosphorylation of interleukin(IL)-24 is required for mediating its anti-cancer activity[J]. Oncotarget,2015,6(18):16271-16286.
 Zissler U M, Chaker A M, Effner R, et al. Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways[J]. Mucosal Immunol,2016,9(4):917-926.
 Bao A, Che K F, Bozinovski S, et al. Recombinant human IL-26 facilitates the innate immune response to endotoxin in the bronchoalveolar space of mice in vivo[J]. PLoS One,2017,12(12):e188909.
 Tengvall S, Che K F, Linden A. Interleukin-26: An Emerging Player in Host Defense and Inflammation[J]. J Innate Immun,2016,8(1):15-22.
 Corvaisier M, Delneste Y, Jeanvoine H, et al. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation[J]. PLoS Biol,2012,10(9):e1001395.
 Truong A D, Park B, Ban J, et al. The novel chicken interleukin 26 protein is overexpressed in T cells and induces proinflammatory cytokines[J]. Vet Res,2016,47(1):65-74.
 Konradsen J R, Nordlund B, Levanen B, et al. The cytokine interleukin-26 as a biomarker in pediatric asthma[J]. Respir Res,2016,17:32-35.